Company / Profit Margin
PUMA BIOTECHNOLOGY, INC. Profit Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
9.2%
FY2025
5-year range
-27.8% / 9.2%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has increased for 7 consecutive years, from -4541.9% in FY2018 to 9.2% in FY2025.
Based on SEC 10-K filings.
9.2% in FY2025 with a 5-year CAGR of +54.4%.
Improved from -11.5% to 9.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +35.8pp
- 5-Year Change
- +54.4pp
- 10-Year Change
- -
Key checks
Key Insights
- Lowest profit margin in the period was in FY2018.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 9.2% | - |
| FY2024 | 0.0% | +100.0% |
| FY2023 | -11.5% | +56.8% |
| FY2022 | -26.7% | +4.0% |
| FY2021 | -27.8% | +38.6% |
| FY2020 | -45.3% | +95.7% |
| FY2019 | -1054.6% | +76.8% |
| FY2018 | -4541.9% | -425.5% |
| FY2017 | -864.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026